Oxidative stress and fibrosis in incipient myocardial dysfunction in type 2 diabetic patients.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  International Journal of Cardiology

• Publication date

  2004-05-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/J.IJCARD.2004.03.009PMID 15860383
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular motors

  2003cited by this paper
• Parameters of oxidative stress in children with Type 1 diabetes mellitus and their relatives.

  2003cited by this paper
• Echocardiographic detection of early diabetic myocardial disease.

  2003cited by this paper
• Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis.

  2002cited by this paper
• Assessment of Diastolic Function With Doppler Tissue Imaging to Predict Genotype in Preclinical Hypertrophic Cardiomyopathy

  2002influential reference
• Doppler-Derived Myocardial Systolic Strain Rate Is a Strong Index of Left Ventricular Contractility

  2002cited by this paper
• Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes.

  2001cited by this paper
• OXIDANT AND ANTIOXIDANT SYSTEMS IN NIDDM PATIENTS: INFLUENCE OF VITAMIN E SUPPLEMENTATION

  2001cited by this paper
• Oxidative Stress and Male IGF-1, Gonadotropin and Related Hormones in Diabetic Patients

  2001cited by this paper
• Relation of tissue Doppler derived myocardial velocities to myocardial structure and beta-adrenergic receptor density in humans.

  2000cited by this paper
• Impact of diabetes on cardiac structure and function: the strong heart study.

  2000cited by this paper
• Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease.

  2000cited by this paper
• Long-axis contraction of the ventricles: a modern approach, but described already by Leonardo da Vinci.

  2000cited by this paper
• Report of the expert committee on the diagnosis and classification of diabetes mellitus.

  1999cited by this paper
• Reproducibility of pulsed wave tissue Doppler echocardiography.

  1999cited by this paper
• Assessment of left ventricular systolic wall motion velocity with pulsed tissue Doppler imaging: comparison with peak dP/dt of the left ventricular pressure curve.

  1998cited by this paper
• Subcellular remodeling and heart dysfunction in chronic diabetes.

  1998cited by this paper
• A simple, rapid, highly sensitive and reproducible quantification method for plasma malondialdehyde by high-performance liquid chromatography.

  1998cited by this paper
• Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function.

  1997cited by this paper
• Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

  1997cited by this paper
• An index of early left ventricular filling that combined with pulsed Doppler peak E velocity may estimate capillary wedge pressure.

  1997cited by this paper
• Clinical application of pulsed Doppler tissue imaging for assessing abnormal left ventricular relaxation.

  1997cited by this paper
• Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures.

  1997cited by this paper
• Mitral annular descent velocity by tissue Doppler echocardiography as an index of global left ventricular function.

  1996cited by this paper
• The myocardial and vascular pathology of diabetic cardiomyopathy.

  1996cited by this paper
• Diabetic Cardiomyopathy: A unique entity or a complication of coronary artery disease?

  1995cited by this paper
• Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension.

  1994influential reference
• Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements

  1978cited by this paper
• Echocardiographic Determination of Left Ventricular Mass in Man: Anatomic Validation of the Method

  1977cited by this paper
• Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy.

  1976cited by this paper
• Morbidity and Mortality in Diabetics In the Framingham Population: Sixteen Year Follow-up Study

  1974cited by this paper

• Ginkgo biloba extract protects against diabetic cardiomyopathy by restoring autophagy via adenosine monophosphate‐activated protein kinase/mammalian target of the rapamycin pathway modulation

  2023cites this paper
• A high-sucrose diet exacerbates the left ventricular phenotype in a high fat-fed streptozotocin rat model of diabetic cardiomyopathy.

  2023cites this paper
• Fibronectin improves the impaired calcium signaling and myofilament activation in diabetic cardiomyocytes

  2022cites this paper
• Effect of sodium glucose cotransporter 2 inhibitors on cardiac function and cardiovascular outcome: a systematic review

  2019cites this paper
• Effect of Tofogliflozin on Systolic and Diastolic Cardiac Function in Type 2 Diabetic Patients

  2019cites this paper
• Effects of Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes Mellitus in Open-Label, Marker-Stratified Randomized, Parallel-Group Comparison, Standard Treatment-Controlled Multicenter Trial (TOPLEVEL Study): Rationale and Study Design

  2019cites this paper
• Potential mechanisms responsible for cardioprotective effects of sodium–glucose co-transporter 2 inhibitors

  2018cites this paper
• Of mice and men: models and mechanisms of diabetic cardiomyopathy

  2018cites this paper
• Are targeted therapies for diabetic cardiomyopathy on the horizon?

  2017cites this paper
• DIABETIC CARDIOMYOPATHY: A REVIEW

  2016cites this paper
• THE EFFECT OF 8 WEEKS REGULAR SWIMMING EXERCISE ON THE CARDIAC LEVELS OF MATRIX METTALOPROTEINASE-2 AND TRANSFORMING GROWTH FACTOR-β1 IN DIABETIC RATS

  2016cites this paper
• Diabetic cardiomyopathy: a clinical entity or a cluster of molecular heart changes?

  2016cites this paper
• Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signaling.

  2015cites this paper
• Diabetic cardiomyopathy: from pathophysiology to treatment.

  2014cites this paper
• Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.

  2014cites this paper
• The Ski–Zeb2–Meox2 pathway provides a novel mechanism for regulation of the cardiac myofibroblast phenotype

  2014cites this paper
• Diabetic Cardiomyopathy: From Pathophysiology

  2014cites this paper
• Diabetes and chronic heart failure: from diabetic cardiomyopathy to therapeutic approach.

  2013cites this paper
• Eeva Hookana CHARACTERISTICS OF VICTIMS OF NON-ISCHEMIC SUDDEN CARDIAC DEATH

  2012cites this paper
• Diabetic cardiomyopathy: myth or reality?

  2012cites this paper
• Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes

  2012cites this paper
• Characteristics of victims of non-ischemic sudden cardiac death

  2012cites this paper
• Diabetic cardiomyopathy and post-infarct ventricular remodelling

  2011cites this paper
• Diabetic cardiomyopathy and post-infarct ventricular remodelling Effects of levosimendan in a rodent model of type II diabetes

  2011cites this paper
• Management of cardiac fibrosis in diabetic rats; the role of peroxisome proliferator activated receptor gamma (PPAR-gamma) and calcium channel blockers (CCBs)

  2011cites this paper
• Diabetic cardiomyopathy and post-infarct ventricular remodelling : Effects of levosimendan in a rodent model of type II diabetes

  2011cites this paper
• Diabetic cardiomyopathy, causes and effects

  2010cites this paper
• Circulating Biomarkers of Collagen Metabolism in Cardiac Diseases

  2010cites this paper
• Cardiac impairment in rabbits fed a high-fat diet is counteracted by dehydroepiandrosterone supplementation.

  2009cites this paper
• Clinical manifestations of diabetic cardiomyopathy

  2009cites this paper
• Biomarkers of extracellular matrix turnover.

  2009cites this paper
• 輸液治療部分恢復出血性休克加乘誘發糖尿病大鼠造成之心肌傷害機轉探討; Resuscitation partially restores the synergistic cardiac damage induced by hemorrhagic shock in diabetic rats

  2009cites this paper
• Clinical manifestations of

  2009cites this paper
• Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats.

  2008cites this paper
• Regulation of Oxidative Stress and Cardioprotection in Diabetes Mellitus

  2008cites this paper
• Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers

  2008cites this paper
• The effects of acute oral antioxidants on diving‐induced alterations in human cardiovascular function

  2007cites this paper
• [Diabetic cardiomyopathy].

  2007cites this paper
• revisão Miocardiopatia Diabética

  2007cites this paper
• [Left ventricular diastolic function and dysfunction: a single cardiac target for various systemic diseases].

  2007cites this paper
• Serum carboxy-terminal propeptide of type I procollagen (PIP) is a marker of diastolic dysfunction in patients with early type 2 diabetes mellitus.

  2007cites this paper
• Effect of Antioxidants on Myocardial Damage in Streptozotocin-Induced Diabetic Rats

  2006cites this paper
• Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes.

  2006cites this paper
• Diabetic cardiomyopathy.

  2006cites this paper